Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1816

1.

The use of botulinum toxin type A in the treatment of HTLV-1-associated overactive bladder refractory to conventional therapy.

Carneiro Neto JA, Bittencourt VG, de Oliveira C, Andrade R, de Carvalho EM.

Rev Soc Bras Med Trop. 2014 Jul;47(4):528-32.

PMID:
25229299
[PubMed - in process]
Free Article
2.

Peroral endoscopic myotomy (POEM) for nutcracker esophagus. Three cases with 12 months follow-up.

Kristensen HO, Bjerregaard NC, Rask P, Mortensen FV, Kunda R.

Scand J Gastroenterol. 2014 Sep 16:1-5. [Epub ahead of print]

PMID:
25225846
[PubMed - as supplied by publisher]
3.

Urinary incontinence in women.

Wood LN, Anger JT.

BMJ. 2014 Sep 15;349:g4531. doi: 10.1136/bmj.g4531. Review.

PMID:
25225003
[PubMed - as supplied by publisher]
Free Article
4.

Cosmetic Microdroplet Botulinum Toxin A Forehead Lift: A New Treatment Paradigm.

Steinsapir KD, Rootman D, Wulc A, Hwang C.

Ophthal Plast Reconstr Surg. 2014 Sep 11. [Epub ahead of print]

PMID:
25216199
[PubMed - as supplied by publisher]
5.

Guidelines for practical usage of botulinum toxin type A (BoNTA) for refractory idiopathic overactive bladder management: Translation of French recommendations.

Hermieu JF, Ballanger P, Amarenco G, Chartier-Kastler E, Cosson M, Costa P, Fatton B, Saussine C, Denys P, Gamé X, Haab F, Karsenty G, Le Normand L, Ruffion A, Deffieux X.

Prog Urol. 2014 Sep;24(11):e1-7. doi: 10.1016/j.purol.2014.06.005. Epub 2014 Jul 9.

PMID:
25214455
[PubMed - in process]
Free Article
6.
7.

Botox enhancing eyebrow elevation in external ophthalmoplegia ptosis.

Putterman AM.

Ophthal Plast Reconstr Surg. 2014 Sep-Oct;30(5):444-5. doi: 10.1097/IOP.0000000000000292. No abstract available.

PMID:
25203481
[PubMed - in process]
8.

Use of OnabotulinumtoxinA for Overactive Bladder with Concomitant Warfarin.

Peters GL, Vouri SM.

Consult Pharm. 2014;29(7):480-6. doi: 10.4140/TCP.n.2014.480.

PMID:
25203108
[PubMed - in process]
9.

Evaluation of headache relief with cosmetic onabotulinumtoxinA injections.

Goldman ND, Dorton LH, Marcum KK, Gilbert RM, Sandoval LF.

J Cosmet Dermatol. 2014 Sep;13(3):224-31. doi: 10.1111/jocd.12098.

PMID:
25196690
[PubMed - in process]
10.

Committee Opinion: OnabotulinumtoxinA and the Bladder.

American Urogynecologic Society and American College of Obstetricians and Gynecologists.

Female Pelvic Med Reconstr Surg. 2014 Sep-Oct;20(5):245-7. doi: 10.1097/SPV.0000000000000112.

PMID:
25181372
[PubMed - in process]
11.

Prospective analysis of the use of OnabotulinumtoxinA (BOTOX) in the treatment of chronic migraine; real-life data in 254 patients from Hull, UK.

Khalil M, Zafar HW, Quarshie V, Ahmed F.

J Headache Pain. 2014 Sep 1;15:54. doi: 10.1186/1129-2377-15-54.

PMID:
25178393
[PubMed - in process]
Free PMC Article
12.

Are there any drawbacks to smoothing out lines and wrinkles with Botox injections?

[No authors listed]

Johns Hopkins Med Lett Health After 50. 2014 Jul;26(6):7. No abstract available.

PMID:
25178125
[PubMed - indexed for MEDLINE]
13.

The topographic anatomy of the masseteric nerve: A cadaveric study with an emphasis on the effective zone of botulinum toxin A injections in masseter.

Kaya B, Apaydin N, Loukas M, Tubbs RS.

J Plast Reconstr Aesthet Surg. 2014 Aug 7. pii: S1748-6815(14)00419-7. doi: 10.1016/j.bjps.2014.07.043. [Epub ahead of print]

PMID:
25175271
[PubMed - as supplied by publisher]
14.

OnabotulinumtoxinA for the treatment of overactive bladder.

Cox L, Cameron AP.

Res Rep Urol. 2014 Jul 21;6:79-89. doi: 10.2147/RRU.S43125. eCollection 2014. Review.

PMID:
25157339
[PubMed]
Free PMC Article
15.

Resources for Hyperhidrosis Sufferers, Patients, and Health Care Providers.

Pieretti LJ.

Dermatol Clin. 2014 Oct;32(4):555-564. doi: 10.1016/j.det.2014.06.011. Epub 2014 Jul 24. Review.

PMID:
25152350
[PubMed - as supplied by publisher]
16.

Botulinum Toxin for Axillary Hyperhidrosis.

Trindade de Almeida AR, Montagner S.

Dermatol Clin. 2014 Oct;32(4):495-504. doi: 10.1016/j.det.2014.06.013. Epub 2014 Jul 15. Review.

PMID:
25152343
[PubMed - as supplied by publisher]
17.

Efficacy and Safety of Intravesical OnabotulinumtoxinA Injection on Elderly Patients with Chronic Central Nervous System Lesions and Overactive Bladder.

Jiang YH, Liao CH, Tang DL, Kuo HC.

PLoS One. 2014 Aug 22;9(8):e105989. doi: 10.1371/journal.pone.0105989. eCollection 2014.

PMID:
25148378
[PubMed - in process]
Free PMC Article
18.

Herpes zoster ophthalmicus following onabotulinumtoxinA administration for chronic migraine: A case report and literature review.

Gadient PM, Smith JH, Ryan SJ.

Cephalalgia. 2014 Aug 18. pii: 0333102414544974. [Epub ahead of print]

PMID:
25135654
[PubMed - as supplied by publisher]
19.
20.

Long-term efficacy, safety, and side effect profile of botulinum toxin in dystonia: A 20-year follow-up.

Ramirez-Castaneda J, Jankovic J.

Toxicon. 2014 Aug 15. pii: S0041-0101(14)00205-0. doi: 10.1016/j.toxicon.2014.07.009. [Epub ahead of print]

PMID:
25130293
[PubMed - as supplied by publisher]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk